In the first half of 2022 the number of deals relating to healthtech decreased significantly by 40% from the same period in 2021.
This marks an acceleration in growth from the 53.6% decrease in deals that occurred in H2 2021 relative to the same period a year earlier.
GlobalData’s deals database looks at mergers, acquisitions and venture capital and private equity investments taking place daily between thousands of companies across the world.